Cas:52648-13-2 3-(2-Amino-ethyl)-5-methoxy-1H-indole-2-carboxylic acid manufacturer & supplier

We serve Chemical Name:3-(2-Amino-ethyl)-5-methoxy-1H-indole-2-carboxylic acid CAS:52648-13-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-(2-Amino-ethyl)-5-methoxy-1H-indole-2-carboxylic acid

Chemical Name:3-(2-Amino-ethyl)-5-methoxy-1H-indole-2-carboxylic acid
CAS.NO:52648-13-2
Synonyms:3-(2-Amino-ethyl)-5-methoxy-1H-indole-2-carboxylic acid
Molecular Formula:C12H14N2O3
Molecular Weight:234.25100
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:489.9ºC at 760 mmHg
Density:1.339g/cm3
Index of Refraction:1.668
PSA:88.34000
Exact Mass:234.10000
LogP:2.07620

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-(2-Amino-ethyl)-5-methoxy-1H-indole-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(2-Amino-ethyl)-5-methoxy-1H-indole-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(2-Amino-ethyl)-5-methoxy-1H-indole-2-carboxylic acid Use and application,3-(2-Amino-ethyl)-5-methoxy-1H-indole-2-carboxylic acid technical grade,usp/ep/jp grade.


Related News: Soliris would need a “substantial discount” to reach a more appropriate price, according to its report. Using the widely leveraged measure for disease burden known as quality-adjusted life year (QALY), ICER calculated a range of $6,900 to achieve $50,000 per QALY to $25,700 to hit $200,000 per QALY. 2-Bromo-3,4,5,6-tetrafluorobenzoic acid manufacturers The products approved for Natural Biogenex under PLI are betamethasone, dexamethasone and prednisolone which utilize a combination of fermentation and chemical synthesis steps. 3,4,5-trithiaheptane suppliers Soliris would need a “substantial discount” to reach a more appropriate price, according to its report. Using the widely leveraged measure for disease burden known as quality-adjusted life year (QALY), ICER calculated a range of $6,900 to achieve $50,000 per QALY to $25,700 to hit $200,000 per QALY. Bromophenol Blue sodium salt vendor & factory Its approval has since been called into question, however, and the head of the FDA is now calling for a federal investigation looking into interactions between agency staff and the biotech company.,The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria.